Dual-targeting of CD44 and CD133: a promising therapeutic strategy for glioblastoma treatment
Abstract The World Health Organization has classified glioblastoma as a grade IV tumor, the highest grade. Despite improvements in neurosurgery, chemotherapy, and radiation therapy, glioblastoma remains one of the most resistant tumors, and it consistently recurs. Glioblastoma cells that co-express...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SpringerOpen
2026-03-01
|
| Serija: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s41983-026-01141-0 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|